You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complement C1 Inactivator Proteins

Showing 1 - 25 of 8,409
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy Trial in Korea, Republic of, New Zealand, Thailand

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • +2 more
  • Camperdown, New South Wales, Australia
  • +19 more
Sep 13, 2022

Traumatic Brain Injury, Trauma, Head Trial in Den Haag, Leiden, Rotterdam (C1 Inhibitor, Human, Placebo)

Recruiting
  • Traumatic Brain Injury
  • Trauma, Head
  • C1 Inhibitor, Human
  • Placebo
  • Den Haag, Netherlands
  • +2 more
Sep 6, 2021

Hereditary Angioedema Trial in Moscow, Rostov-on-Don, Stavropol' (GNR-038, 50 ??/ kg, GNR-038, 100 ??/ kg, Berinert®, 20 ??/ kg)

Withdrawn
  • Hereditary Angioedema
  • GNR-038, 50 МЕ/ kg
  • +4 more
  • Moscow, Russian Federation
  • +4 more
Jan 21, 2022

Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))

Completed
  • Hereditary Angioedema
  • C1 esterase inhibitor [human] (C1INH-nf)
  • San Diego, California
  • +5 more
Jun 1, 2021

HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)

Active, not recruiting
  • HIV Infections
  • env (A,B,C,A/E)/gag (C) DNA Vaccine
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2022

C3G, IC-MPGN, C3 Glomerulopathy Trial in Worldwide (Pegcetacoplan, Placebo)

Recruiting
  • C3G
  • +11 more
  • Birmingham, Alabama
  • +27 more
Aug 4, 2022

End Stage Renal Disease, Chronic Kidney Diseases Trial in Los Angeles (Berinert, Placebo)

Active, not recruiting
  • End Stage Renal Disease
  • Chronic Kidney Diseases
  • Los Angeles, California
    Cedars Sinai Medical Center
Jan 5, 2022

Donor-specific Antibodies After Liver Transplantation

Completed
  • Liver Transplant
    • Lille, France
      CHRU, Hôpital Claude Huriez
    Mar 24, 2021

    CVI - Common Variable Immunodeficiency Trial in Centennial (C1-esterase inhibitor [recombinant] (C1-INH-R))

    Completed
    • CVI - Common Variable Immunodeficiency
    • C1-esterase inhibitor [recombinant] (C1-INH-R)
    • Centennial, Colorado
      IMMUNOe Research Centers
    Feb 11, 2021

    Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))

    Completed
    Has Results
    • Hereditary Angioedema
    • C1 esterase inhibitor [human] (C1INH-nf)
    • Hoover, Alabama
    • +47 more
    May 19, 2021

    Stargardt Disease 1 Trial in Worldwide (Zimura, Sham)

    Recruiting
    • Stargardt Disease 1
    • Phoenix, Arizona
    • +41 more
    Sep 7, 2022

    Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))

    Completed
    Has Results
    • Hereditary Angioedema
    • C1 esterase inhibitor [human] (C1INH-nf)
    • Scottsdale, Arizona
    • +29 more
    May 19, 2021

    Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))

    Completed
    Has Results
    • Hereditary Angioedema
    • C1 esterase inhibitor [human] (C1INH-nf)
    • Placebo (saline)
    • Hoover, Alabama
    • +36 more
    Jun 3, 2021

    Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy Trial in Ranica (C3NEF assay)

    Not yet recruiting
    • Hemolytic-Uremic Syndrome
    • +2 more
    • C3NEF assay
    • Ranica, BG, Italy
      Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
    Aug 9, 2023

    Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))

    Completed
    Has Results
    • Hereditary Angioedema
    • C1 esterase inhibitor [human] (C1INH-nf)
    • Placebo (saline)
    • Scottsdale, Arizona
    • +15 more
    Jun 1, 2021

    Hereditary Angioedema Trial in United States (C1 inhibitor (human) [C1 INH])

    Completed
    Has Results
    • Hereditary Angioedema
    • C1 inhibitor (human) [C1 INH]
    • Scottsdale, Arizona
    • +10 more
    Jun 17, 2021

    Graft Rejection Trial in Germany, United States (Placebo, C1 Esterase Inhibitor (Human))

    Completed
    Has Results
    • Graft Rejection
    • Placebo
    • C1 Esterase Inhibitor (Human)
    • Los Angeles, California
    • +4 more
    Jun 2, 2021

    Hereditary Angioedema Types I and II Trial in Germany, United States (C1-esterase inhibitor - single intravenous dose,

    Completed
    Has Results
    • Hereditary Angioedema Types I and II
    • C1-esterase inhibitor - single intravenous dose
    • +3 more
    • Atlanta, Georgia
    • +7 more
    Jan 29, 2021

    Hereditary Angioedema Trial in United States (CINRYZE with rHuPH20)

    Completed
    Has Results
    • Hereditary Angioedema
    • CINRYZE with rHuPH20
    • Scottsdale, Arizona
    • +3 more
    Jun 16, 2021

    Hereditary Angioedema Types I and II Trial in Worldwide (Low-volume C1-esterase inhibitor, Higher-volume C1-esterase inhibitor,

    Completed
    Has Results
    • Hereditary Angioedema Types I and II
    • Low-volume C1-esterase inhibitor
    • +3 more
    • Birmingham, Alabama
    • +38 more
    Jan 11, 2021

    Systemic Lupus Erythematosus and Antiphospholipid Syndrome

    Recruiting
    • Systemic Lupus Erythematosus
    • Antiphospholipid Syndrome
      • Chicago, Illinois
      • +9 more
      Sep 8, 2022

      Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

      Active, not recruiting
      Has Results
      • Atypical Hemolytic Uremic Syndrome (aHUS)
      • Ravulizumab
      • Aurora, Colorado
      • +19 more
      Nov 16, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in China

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
        • Hefei, Anhui, China
        • +23 more
        Nov 23, 2023

        Autoimmune Haemolytic Anaemia Trial in Worldwide (BIVV020)

        Active, not recruiting
        • Autoimmune Haemolytic Anaemia
        • Essen, Germany
        • +4 more
        Jan 19, 2023

        Link Between Complement Activation and IgA Nephropathy Severity

        Recruiting
        • IgA Nephropathy Severity in Kidney Transplantation
        • IgAN patients
        • Strasbourg, France
          Service de néphrologie
        Aug 18, 2022